Unilever has announced on Monday (3) that it has signed an agreement to acquire the Health Food Drinks portfolio (GSK HFD) of GlaxoSmithKline (GSK) in India, Bangladesh, and 20 other predominantly Asian markets. The transaction consists of three elements including, all-equity merger of Hindustan Unilever Ltd (HUL) with the publicly listed GSK Consumer Healthcare India (GSK CH India), acquisition of 82 per cent stake in GSK Bangladesh Limited (GSK Bangladesh), and acquisition of certain other commercial operations and assets outside India, said Unilever in a statement. Unilever’s share of the total consideration is €3.3 billion payable using a combination of…
You do not have access to this content. You need to subscribe.
